Jiangsu Nanfang Medical Co., Ltd.

Equities

603880

CNE100002WH0

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 03:30:00 14/05/2024 am IST 5-day change 1st Jan Change
3.37 CNY -4.80% Intraday chart for Jiangsu Nanfang Medical Co., Ltd. -10.37% -33.79%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Ren Weiguo signed share transfer agreement to acquire 8% stake in Jiangsu Nanfang Medical Co., Ltd. from Li Ping for CNY 99.9 million. CI
Jiangsu Nanfang Medical Co., Ltd.(SHSE:603880) dropped from Shanghai Stock Exchange A Share Index CI
Jiangsu Nanfang Medical Co., Ltd.(SHSE:603880) dropped from Shanghai Stock Exchange Composite Index CI
Suzhou Fengruida Optoelectronics Technology Co., Ltd. signed a share transfer agreement to acquire 8% stake in Jiangsu Nanfang Medical Co., Ltd. from Li Ping for approximately CNY 140 million. CI
Jiangsu Nanfang Medical Co., Ltd. announced that it expects to receive CNY 299.200902 million in funding from Suzhou Fengruida Optoelectronics Technology Co., Ltd. CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jiangsu Nanfang Medical Unit to Apply For 100 Million Yuan Bank Loan MT
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Inner Mongolia Huaxi Biotechnology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Jiangsu Nanfang Medical Co., Ltd. CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Shen Zhezhong cancelled the acquisition of 60% stake in Shanghai Milene Biotechnology Co., Ltd. CI
Jiangsu Nanfang Medical's Controlling Shareholder and Party Acting in Concert Plan to Unload Stakes CI
Anhui Nanwei Medical Products Co., Ltd. announced that it expects to receive CNY 75 million in funding from Jiangsu Nanfang Medical Co., Ltd. CI
Jiangsu Nanfang Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Jiangsu Nanfang Medical Co., Ltd. cancelled the acquisition of 65% in Anhui Huize New Material Technology Co., Ltd. from Shu Zhengjun. CI
Chart Jiangsu Nanfang Medical Co., Ltd.
More charts
Jiangsu Nanfang Medical Co., Ltd. is a China-based company which is mainly engaged in manufacture and sales of medical dressings and pharmaceutical products. The Company is mainly engaged in research and development, manufactures and sales of transdermal products, medical tape and bandages, sports protection products, first-aid kits, nursing products and others. The Company’s main products include Band-Aid, patches, medical tapes, plaster dressings, sports protection products, first-aid kits, care products and other products. The Company’s brands include MIAO-SHOU, Oushun and others.
More about the company
  1. Stock Market
  2. Equities
  3. 603880 Stock
  4. News Jiangsu Nanfang Medical Co., Ltd.
  5. Jiangsu Nanfang Medical Unit to Apply For 100 Million Yuan Bank Loan
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW